What serum ferritin cutoff should be used to evaluate iron deficiency in adult males?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ferritin Cutoff for Iron Deficiency in Adult Males

For adult males without inflammation, use a serum ferritin threshold of ≤30 ng/mL to diagnose iron deficiency, but increase this to ≤50 ng/mL if the patient has symptoms (fatigue, restless legs, pica, exercise intolerance) or ongoing risk factors for iron deficiency. 1

Evidence-Based Thresholds

The most recent American Society of Hematology 2026 guidelines provide clear diagnostic cutoffs based on systematic review of 17 studies involving over 5,000 individuals 1:

  • ≤30 ng/mL: Standard threshold for asymptomatic adult males without inflammation (sensitivity 67%, specificity 96%)
  • ≤50 ng/mL: Appropriate threshold when males have:
    • Symptoms associated with iron deficiency (fatigue, decreased cognition, restless legs syndrome, pica, exercise intolerance)
    • Risk factors including GI blood loss, inflammatory bowel disease, post-bariatric surgery, blood donation, vegetarian/vegan diet, chronic NSAID use, or peptic ulcer disease 1

The ≤50 ng/mL threshold has higher sensitivity (89%) at the cost of slightly lower specificity (86%), which is acceptable when clinical suspicion is elevated 1.

Why Not Lower Thresholds?

The traditional ≤15 ng/mL cutoff has unacceptably low sensitivity (41%), missing the majority of iron-deficient males 1. This outdated threshold contributes to structural underdiagnosis of iron deficiency 2. The 2026 ASH guidelines explicitly recommend against using ≤15 ng/mL because it fails to identify iron deficiency before significant functional consequences develop.

Special Circumstances in Males

With inflammation (IBD, cancer, chronic kidney disease, heart failure, rheumatologic disorders):

  • Ferritin alone is insufficient because it's an acute-phase reactant
  • Use both ferritin <100 ng/mL OR transferrin saturation <20% (fasting sample)
  • TSAT should be drawn after 5-9 hours fasting, including from multivitamins 1

Older males (>50 years):

  • The same ≤30 ng/mL threshold applies
  • Some data suggest slightly higher thresholds (32.5 μg/L) may be appropriate, but current guidelines maintain ≤30 ng/mL as standard 3

Clinical Algorithm

  1. Measure serum ferritin in males with anemia, symptoms of iron deficiency, or risk factors
  2. Check CRP to exclude inflammation (which falsely elevates ferritin)
  3. Without inflammation:
    • Ferritin ≤30 ng/mL = iron deficiency
    • Ferritin ≤50 ng/mL with symptoms/risk factors = iron deficiency
  4. With inflammation:
    • Add fasting TSAT
    • Diagnose iron deficiency if ferritin <100 ng/mL OR TSAT <20%

Critical Pitfalls

  • Don't rely on hemoglobin alone – iron deficiency causes symptoms even without anemia 1
  • Don't miss inflammation – always check CRP when ferritin is "normal" but clinical suspicion is high 4
  • Don't use manufacturer reference ranges – these typically report lower limits of 20-25 ng/mL for males, which are derived from flawed methodology that didn't exclude iron-deficient individuals 2

The Lancet Haematology 2025 consensus supports ferritin <50 ng/mL as a reasonable starting point for adults, acknowledging that no perfect cutoff exists but emphasizing that higher thresholds prevent missing clinically significant iron deficiency 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.